These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 803581)

  • 21. A simplified approach to meningococcal disease prophylaxis.
    Jacobson JA; Fraser DW
    JAMA; 1976 Aug; 236(9):1053-4. PubMed ID: 823346
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bacteriological considerations on epidemic cerebrospinal meningitis].
    Mihalcu F; Paşolescu G; Mermezan E; Cuciureanu G; Dumitrescu S
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):601-7. PubMed ID: 5000095
    [No Abstract]   [Full Text] [Related]  

  • 23. "...one giant leap..."?
    Feldman HA
    N Engl J Med; 1970 Feb; 282(8):450. PubMed ID: 4983755
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylaxis of contacts of patients with meningococcal infection.
    Gaebler JW; Kleiman MB; Reynolds JK; Allen SD; Smith JW
    J Indiana State Med Assoc; 1983 Dec; 76(12):828-30. PubMed ID: 6418826
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland.
    Sivonen A; Renkonen OV; Weckström P; Koskenvuo K; Raunio V; Mäkelä PH
    J Infect Dis; 1978 Mar; 137(3):238-44. PubMed ID: 416147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina.
    Woods CR; Smith AL; Wasilauskas BL; Campos J; Givner LB
    J Infect Dis; 1994 Aug; 170(2):453-6. PubMed ID: 8035036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccine prophylaxis and chemoprophylaxis of cerebrospinal meningitis].
    Soscia M
    Ann Sclavo; 1979; 21(3):307-46. PubMed ID: 121683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current trends in treatment and prevention of meningococcal disease.
    Crowder JG
    J Indiana State Med Assoc; 1970 Sep; 63(9):1000-1. PubMed ID: 4990170
    [No Abstract]   [Full Text] [Related]  

  • 29. The epidemiology of meningococcal infections in England and Wales, 1912-1983.
    Abbott JD; Jones DM; Painter MJ; Young SE
    J Infect; 1985 Nov; 11(3):241-57. PubMed ID: 3936880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meningococcal disease in 2 siblings--failure of rifampicin prophylaxis].
    Kolmos HJ; Grytter C; Lind I
    Ugeskr Laeger; 1987 Nov; 149(48):3267-8. PubMed ID: 3124322
    [No Abstract]   [Full Text] [Related]  

  • 31. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin.
    Cooper ER; Ellison RT; Smith GS; Blaser MJ; Reller LB; Paisley JW
    J Pediatr; 1986 Jan; 108(1):93-6. PubMed ID: 3080574
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
    Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
    J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of rifampin on the carrier state of Neisseria meningitidis and drug-sensitivity test (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):371-2. PubMed ID: 6806022
    [No Abstract]   [Full Text] [Related]  

  • 34. Five cases of meningitis due to sulfonamide-resistant meningococci.
    Holmgren EB; Tunevall G
    Scand J Infect Dis; 1973; 5(1):75-6. PubMed ID: 4199381
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of rifampin and minocycline on meningococcal carrier rates.
    Guttler RB; Counts GW; Avent CK; Beaty HN
    J Infect Dis; 1971 Aug; 124(2):199-205. PubMed ID: 4942060
    [No Abstract]   [Full Text] [Related]  

  • 36. Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
    Devine LF; Hannah JM; Hagerman CR; Rhode SL; Peckinpaugh RO
    Mil Med; 1973 Jan; 138(1):20-4. PubMed ID: 4630051
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 38. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary: prophylaxis for contacts of patients with meningococcal disease.
    Gold R
    Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315
    [No Abstract]   [Full Text] [Related]  

  • 40. [Failure of chemoprophylaxis due to resistance of Neisseria meningitidis to rifampicin].
    Bordessoule A; Hoppé A; Ringuier B; Giniès JL
    Arch Pediatr; 2007 Jan; 14(1):99-100. PubMed ID: 17145173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.